Regeneron Pharmaceuticals, Inc. (REGN) Covered Calls
Regeneron Pharmaceuticals, Inc. is engaged in the research, development, and commercialization of therapeutics to treat human disorders and conditions.
You can sell covered calls on Regeneron Pharmaceuticals, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for REGN (prices last updated Tue 4:16 PM ET):
| Regeneron Pharmaceuticals, Inc. (REGN) Stock Quote | ||||||
|---|---|---|---|---|---|---|
| Last | Change | Bid | Ask | Volume | P/E | Market Cap |
| 740.01 | +15.14 | 740.00 | 756.12 | 928K | 18 | 80 |
| Covered Calls For Regeneron Pharmaceuticals, Inc. (REGN) | ||||||
|---|---|---|---|---|---|---|
| Expiration | Strike | Call Bid | Net Debit | Return If Flat |
Annualized Return If Flat |
|
| Dec 20 | 740 | 6.80 | 749.32 | -1.2% | -109.5% | |
| Jan 17 | 740 | 30.60 | 725.52 | 2.0% | 22.8% | |
| Subscribers get access to the full covered call chain, and more features. | ||||||
Want to make money with covered calls? Sign Up For A Free Trial
Extended Business Description
Regeneron Pharmaceuticals, Inc. operates as a biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets medicines for eye diseases, colorectal cancer and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, asthma and atopic dermatitis. The company's products include EYLEA (aflibercept) injection, which is used for the treatment of neovascular age related macular degeneration; ARCALYST (rilonacept), which is used for the treatment of Cryopyrin-Associated Periodic Syndrome, including Familial Cold Auto-inflammatory Syndrome and Muckle-Wells Syndrome; and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion. It has active research and development programs in many disease areas, including ophthalmology, inflammation, cancer, and hypercholesterolemia. The company was founded by Alferd G. Gilman, Leonard S. Schleifer and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.
| Top 10 Open Interest For Dec 20 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | NVDA covered calls | 6. | EEM covered calls | 1. | QUBT covered calls | |
| 2. | SPY covered calls | 7. | IWM covered calls | 2. | CRVS covered calls | |
| 3. | XLF covered calls | 8. | TLT covered calls | 3. | WVE covered calls | |
| 4. | QQQ covered calls | 9. | KWEB covered calls | 4. | QBTS covered calls | |
| 5. | FXI covered calls | 10. | TSLA covered calls | 5. | HUT covered calls | |
Want more examples? REGL Covered Calls | REI Covered Calls
